Clinical Trial Update: A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia

View source ↗

Summary

This clinical trial updates how CDK4/6 inhibitors are used in people with advanced or metastatic breast cancer in Australia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)
• KISQALI (ribociclib)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Status: COMPLETED